IFNA1 and chronic myelogenous leukemia, BCR-ABL1 positive: Enlarged Memory T-Cell Pool and Enhanced Th1-Type Responses in Chronic Myeloid Leukemia Patients Who Have Successfully Discontinued IFN-α Monotherapy